Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 20:00
Onconetix Total Assets (Quarterly): 59.46M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 59.46M |
| March 31, 2024 | 75.03M |
| December 31, 2023 | 87.52M |
| September 30, 2023 | 27.88M |
| June 30, 2023 | 29.75M |
| March 31, 2023 | 22.50M |
| December 31, 2022 | 26.31M |
| Date | Value |
|---|---|
| September 30, 2022 | 30.16M |
| June 30, 2022 | 23.63M |
| March 31, 2022 | 19.34M |
| December 31, 2021 | 3.085M |
| September 30, 2021 | 3.422M |
| December 31, 2020 | 4.812M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.085M
Minimum
Dec 2021
87.52M
Maximum
Dec 2023
31.76M
Average
26.31M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 88.19M |
| Shareholders Equity (Quarterly) | -35.81M |
| Debt to Equity Ratio | -0.4216 |
| Current Ratio | 0.0988 |